Oral Antiviral Matches Paxlovid in High-Risk COVID

(MedPage Today) -- An oral remdesivir analogue (VV116) was just as good as nirmatrelvir-ritonavir (Paxlovid) for the treatment of mild-to-moderate COVID-19 in adults at risk for severe disease, and may be safer, results of a phase III trial from...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news